BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng Y, Fu Y, Wang Y, Wang J. The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF. Front Genet 2020;11:955. [PMID: 33061938 DOI: 10.3389/fgene.2020.00955] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Li L, Li J, Zhao B, Huang G, Li X, Xie Z, Zhou Z. The Emerging Role of m6A Modification in Regulating the Immune System and Autoimmune Diseases. Front Cell Dev Biol 2021;9:755691. [PMID: 34869344 DOI: 10.3389/fcell.2021.755691] [Reference Citation Analysis]
2 Xie Z, Li M, Hong H, Xu Q, He Z, Peng Z. Expression of N6-methyladenosine (m6A) regulators correlates with immune microenvironment characteristics and predicts prognosis in diffuse large cell lymphoma (DLBCL). Bioengineered 2021;12:6115-33. [PMID: 34482808 DOI: 10.1080/21655979.2021.1972644] [Reference Citation Analysis]
3 Liu J, Li JN, Wu H, Liu P. The Status and Prospects of Epigenetics in the Treatment of Lymphoma. Front Oncol 2022;12:874645. [PMID: 35463343 DOI: 10.3389/fonc.2022.874645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhao C, Xu G, Zhang X, Ye Y, Cai W, Shao Q. RNA m6A modification orchestrates the rhythm of immune cell development from hematopoietic stem cells to T and B cells. Front Immunol 2022;13:839291. [DOI: 10.3389/fimmu.2022.839291] [Reference Citation Analysis]
5 Zhang T, Liu H, Gao F, Gong W, Cui Y, He J, Li L, Qiu L, Qian Z, Zhou S, Meng B, Ren X, Zhang H, Wang X. m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment. Front Immunol 2022;13:922471. [DOI: 10.3389/fimmu.2022.922471] [Reference Citation Analysis]
6 Cai Y, Feng R, Lu T, Chen X, Zhou X, Wang X. Novel insights into the m6A-RNA methyltransferase METTL3 in cancer. Biomark Res 2021;9:27. [PMID: 33879256 DOI: 10.1186/s40364-021-00278-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liu C, Yang Z, Li R, Wu Y, Chi M, Gao S, Sun X, Meng X, Wang B. Potential roles of N6-methyladenosine (m6A) in immune cells. J Transl Med 2021;19:251. [PMID: 34103054 DOI: 10.1186/s12967-021-02918-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wu X, Ye W, Gong Y. The Role of RNA Methyltransferase METTL3 in Normal and Malignant Hematopoiesis. Front Oncol 2022;12:873903. [PMID: 35574332 DOI: 10.3389/fonc.2022.873903] [Reference Citation Analysis]
9 Xu C, Liang T, Liu J, Fu Y. RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma. Front Pharmacol 2022;13:931501. [DOI: 10.3389/fphar.2022.931501] [Reference Citation Analysis]
10 Zhao Y, Peng H. The Role of N6-Methyladenosine (m6A) Methylation Modifications in Hematological Malignancies. Cancers (Basel) 2022;14:332. [PMID: 35053496 DOI: 10.3390/cancers14020332] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
11 Dong S, Wu Y, Liu Y, Weng H, Huang H. N6 -methyladenosine Steers RNA Metabolism and Regulation in Cancer. Cancer Commun (Lond) 2021;41:538-59. [PMID: 33955720 DOI: 10.1002/cac2.12161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]